Gilead Sciences (GILD) Net Income - Minority (2011 - 2021)

Gilead Sciences has reported Net Income - Minority for 11 years, with the latest figure at -$7.0 million in Q2 2021.

• For the quarter ending Q2 2021, Net Income - Minority rose 93.91% year-over-year to -$7.0 million; the trailing twelve-month figure through Jun 2021 stood at -$7.0 million (up 93.91% YoY), and the FY2020 full-year result was -$19.0 million, up 84.8% from the prior year.
• Net Income - Minority for Q2 2021 stood at -$7.0 million, up from -$12.0 million in the prior quarter.
• The five-year high for Net Income - Minority was -$7.0 million in Q2 2021, with the low at -$476.0 million in Q1 2017.
• Historically, Net Income - Minority has averaged -$144.2 million across 5 years, with a median of -$120.0 million in 2019.
• Annual changes were most pronounced in 2018 — Net Income - Minority slumped 149.15% — and 2021, when it surged 93.91%.
• Gilead Sciences' Net Income - Minority stood at -$59.0 million in 2017, then tumbled by 149.15% to -$147.0 million in 2018, then gained by 14.97% to -$125.0 million in 2019, then soared by 84.8% to -$19.0 million in 2020, then soared by 63.16% to -$7.0 million in 2021.
• The last three Net Income - Minority figures came in at -$7.0 million (Q2 2021), -$12.0 million (Q1 2021), and -$19.0 million (Q4 2020), per Business Quant data.